Skip to: Content
Skip to: Site Navigation
Skip to: Search

THURSDAY, NOVEMBER 26, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter


0

Stem Cells Are Beating Boy's Deadly Disease

Doctors believe treatment may cure skin disorder

Share

(Newser) – A stem cell treatment has apparently cured a 2-year-old boy's rare genetic disease, the Los Angeles Times reports. Nate Liao suffered a disorder that made his skin so fragile, it had to be wrapped in bandages at all times. Now the fatal disease is retreating, and Nate is eating, dressing, and playing with other kids for the first time.

Nate's case is the first to see bone marrow and cord blood cells used to combat a disorder not involving blood, and his brother has also been treated. "Nate's quality of life is forever changed," said a Minnesota doctor who performed the treatment. "Maybe we can take one more disorder off the incurable list."

A clinical associate with Aastrom Biosciences in Ann Arbor, Michigan, opens a container of liquid nitrogen. Inside are specimens of bone-marrow and umbilical-cord cells.
A clinical associate with Aastrom Biosciences in Ann Arbor, Michigan, opens a container of liquid nitrogen. Inside are specimens of bone-marrow and umbilical-cord cells.   (KRT Photos)
A researcher holds a test tube filled with stem cells.
A researcher holds a test tube filled with stem cells.   (AP Photo/Andre Penner)
This photo shows, counterclockwise from top, Noah Liao, 8; Jake Liao, 5; Nate Liao, 2; and Julian Liao, 3. Nate and Jake suffer a rare disease but have been given hope by stem cells from Julian.
This photo shows, counterclockwise from top, Noah Liao, 8; Jake Liao, 5; Nate Liao, 2; and Julian Liao, 3. Nate and Jake suffer a rare disease but have been given hope by stem cells from Julian.   (AP Photo)
« Prev« Prev | Next »Next » Slideshow
0 comments
VIEWING:
 
LEAVE A
COMMENT
Comment Policy
Facebook ConnectPost this comment to Facebook?

After connecting you will have the option to post your comment on your Facebook profile.